Volume 220, Issue 2

Search all Psychopharmacology articles

March 2012

19 articles in this issue

Effects of modafinil on cognitive functions in first episode psychosis
Linda Scoriels
Jennifer H. Barnett
Peter B. Jones
Original Investigation 10 September 2011 Pages: 249 - 258
Blunted vagal reactivity predicts stress-precipitated tobacco smoking
Rebecca L. Ashare
Rajita Sinha
Sherry A. McKee
Original Investigation 21 September 2011 Pages: 259 - 268
Paroxetine-induced reduction of sexual incentive motivation in female rats is not modified by 5-HT_1B or 5-HT_2C antagonists
Helge Kaspersen
Anders Ågmo
Original Investigation 10 September 2011 Pages: 269 - 280
Memory re-consolidation and drug conditioning: an apomorphine conditioned locomotor stimulant response can be enhanced or reversed by a single high versus low apomorphine post-trial treatment
Marinete Pinheiro Carrera
Robert J. Carey
Liana Wermelinger de Mattos
Original Investigation 16 September 2011 Pages: 281 - 291
Predicting psychopharmacological drug effects on actual driving performance (SDLP) from psychometric tests measuring driving-related skills
Joris C. Verster
Thomas Roth
Original Investigation Open access 16 September 2011 Pages: 293 - 301
Paroxetine reduces crying in young women watching emotional movies
Frederik M. van der Veen
Joyce Jorritsma
Ad J. Vingerhoets
Original Investigation Open access 16 September 2011 Pages: 303 - 308
Characterizing smoking topography of cannabis in heavy users
Erin A. McClure
Maxine L. Stitzer
Ryan Vandrey
Original Investigation 16 September 2011 Pages: 309 - 318
Neurohypophyseal hormones manipulation modulate social and anxiety-related behavior in zebrafish
Daniela Braida
Andrea Donzelli
Mariaelvina Sala
Original Investigation 29 September 2011 Pages: 319 - 330
Manipulation of nicotinic acetylcholine receptors differentially affects behavioral inhibition in human subjects with and without disordered baseline impulsivity
Alexandra S. Potter
David J. Bucci
Paul A. Newhouse
Original Investigation 04 October 2011 Pages: 331 - 340
Neurophysiological functioning of occasional and heavy cannabis users during THC intoxication
Eef L. Theunissen
Gerold F. Kauert
Johannes G. Ramaekers
Original Investigation Open access 06 October 2011 Pages: 341 - 350
Memory improvements in elderly women following 16 weeks treatment with a combined multivitamin, mineral and herbal supplement
Helen Macpherson
Kathryn A. Ellis
Andrew Pipingas
Original Investigation 18 October 2011 Pages: 351 - 365
Ethanol withdrawal-induced motor impairment in mice
Scott D. Philibin
Andy J. Cameron
John C. Crabbe
Original Investigation 24 September 2011 Pages: 367 - 378
Restricted role of CRF1 receptor for the activity of brainstem catecholaminergic neurons in the negative state of morphine withdrawal
Juan-Antonio Garcia-Carmona
Pilar Almela
M. Luisa Laorden
Original Investigation 21 September 2011 Pages: 379 - 393
The effect of a novel VMAT2 inhibitor, GZ-793A, on methamphetamine reward in rats
Joshua S. Beckmann
Emily D. Denehy
Michael T. Bardo
Original Investigation 21 September 2011 Pages: 395 - 403
Corticosteroid dependent and independent effects of a cannabinoid agonist on core temperature, motor activity, and prepulse inhibition of the acoustic startle reflex in Wistar rats
Avdesh Avdesh
Vincent Cornelisse
Mathew Thomas Martin-Iverson
Original Investigation 27 September 2011 Pages: 405 - 415
AM2389, a high-affinity, in vivo potent CB₁-receptor-selective cannabinergic ligand as evidenced by drug discrimination in rats and hypothermia testing in mice
Torbjörn U. C. Järbe
Sherrica Tai
Alexandros Makriyannis
Original Investigation 12 October 2011 Pages: 417 - 426
Ammonium pyrrolidine dithiocarbamate and RS 102895 attenuate opioid withdrawal in vivo and in vitro
Ashish K. Rehni
Nirmal Singh
Original Investigation 20 September 2011 Pages: 427 - 438
Comment on: “Dose-effect study of Gelsemium sempervirens in high dilutions on anxiety-related responses in mice” (Magnani P, Conforti A, Zanolin E, Marzotto M and Bellavite P, Psychopharmacology, 2010)
Luigi Cervo
Valter Torri
Letter to the Editors 19 November 2011 Pages: 439 - 440
Response to a comment by Luigi Cervo and Valter Torri on: “Dose–effect study of Gelsemium sempervirens in high dilutions on anxiety-related responses in mice” (Magnani P. et al., Psychopharmacology, 2010)
Paolo Bellavite
Paolo Magnani
Mariaelisabetta Zanolin
Commentary Open access 22 November 2011 Pages: 441 - 442

Volume 220, Issue 2

Effects of modafinil on cognitive functions in first episode psychosis

Blunted vagal reactivity predicts stress-precipitated tobacco smoking

Paroxetine-induced reduction of sexual incentive motivation in female rats is not modified by 5-HT_1B or 5-HT_2C antagonists

Memory re-consolidation and drug conditioning: an apomorphine conditioned locomotor stimulant response can be enhanced or reversed by a single high versus low apomorphine post-trial treatment

Predicting psychopharmacological drug effects on actual driving performance (SDLP) from psychometric tests measuring driving-related skills

Paroxetine reduces crying in young women watching emotional movies

Characterizing smoking topography of cannabis in heavy users

Neurohypophyseal hormones manipulation modulate social and anxiety-related behavior in zebrafish

Manipulation of nicotinic acetylcholine receptors differentially affects behavioral inhibition in human subjects with and without disordered baseline impulsivity

Neurophysiological functioning of occasional and heavy cannabis users during THC intoxication

Memory improvements in elderly women following 16 weeks treatment with a combined multivitamin, mineral and herbal supplement

Ethanol withdrawal-induced motor impairment in mice

Restricted role of CRF1 receptor for the activity of brainstem catecholaminergic neurons in the negative state of morphine withdrawal

The effect of a novel VMAT2 inhibitor, GZ-793A, on methamphetamine reward in rats

Corticosteroid dependent and independent effects of a cannabinoid agonist on core temperature, motor activity, and prepulse inhibition of the acoustic startle reflex in Wistar rats

AM2389, a high-affinity, in vivo potent CB₁-receptor-selective cannabinergic ligand as evidenced by drug discrimination in rats and hypothermia testing in mice

Ammonium pyrrolidine dithiocarbamate and RS 102895 attenuate opioid withdrawal in vivo and in vitro

Comment on: “Dose-effect study of Gelsemium sempervirens in high dilutions on anxiety-related responses in mice” (Magnani P, Conforti A, Zanolin E, Marzotto M and Bellavite P, Psychopharmacology, 2010)

Response to a comment by Luigi Cervo and Valter Torri on: “Dose–effect study of Gelsemium sempervirens in high dilutions on anxiety-related responses in mice” (Magnani P. et al., Psychopharmacology, 2010)

Navigation